Brighton Jones’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
Other funds holding AKBA
Brighton Jones's AKBA Position: Q3 2026 in Review
Brighton Jones sold out of Akebia Therapeutics (AKBA) in Q3 2026, closing a stake of 19,650 shares — an estimated $22.4K sold.
Brighton Jones first reported a position in AKBA in Q2 2026 and held it in 1 quarter. The position peaked at $22.4K in Q2 2026. 125 funds tracked by Wall St. Rank hold AKBA as of Q3 2026.
- Brighton Jones reported no remaining Akebia Therapeutics position as of Q3 2026 after selling out during the quarter.
- Brighton Jones sold 19,650 Akebia Therapeutics shares in Q3 2026, an estimated $22.4K.
- Brighton Jones first reported a position in Akebia Therapeutics in Q2 2026 and held it in 1 quarter.
- Brighton Jones's Akebia Therapeutics position peaked at $22.4K in Q2 2026.
- 125 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.